Evaluation of the Quality and Trustworthiness of Short Videos on Renal Cell Carcinoma Available on Bilibili and TikTok: A Cross-Sectional Analysis - Scorecard - MDSpire
Clinical Scorecard: Evaluation of the Quality and Trustworthiness of Short Videos on Renal Cell Carcinoma Available on Bilibili and TikTok: A Cross-Sectional Analysis
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Patients with renal cell carcinoma, their families, and caregivers.
Care Setting
Key Highlights
Patients often experience psychological issues impacting quality of life.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Regular follow-ups and psychological support for patients are essential, including counseling and support groups.
Risks
Patient & Prescribing Data
Individuals diagnosed with renal cell carcinoma.
Treatment options include surgical and non-surgical interventions, with a focus on personalized care.
Clinical Best Practices
Encourage patients to seek information from reliable sources and provide criteria for evaluating content quality.
The U.S. Food and Drug Administration (FDA) has approved pembrolizumab, an immunotherapy, plus belzutifan, a HIF-2alpha inhibitor, as adjuvant treatment for adult patients with renal cell carcinoma with a clear cell component (ccRCC) at intermediate-high or high risk of recurrence following nephrectomy, with or without resection of metastatic lesions.
